Artwork

Content provided by SWI swissinfo.ch. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SWI swissinfo.ch or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why Are leading Swiss Pharmaceutical Companies Investing in Slovenia?

16:53
 
Share
 

Manage episode 414103800 series 32428
Content provided by SWI swissinfo.ch. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SWI swissinfo.ch or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Send us a Text Message.

Pharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production. Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines.
Articles and videos on Switzerland's investment in Slovenia are available on swissinfo.ch. For other science stories from Switzerland please go to www.swissinfo.ch/science.
Journalist: Jessica Davis Plüss
Host: Jo Fahy
Audio editor/video journalist: Céline Stegmüller & Michele Andina
Distribution and Marketing: Xin Zhang

SWI swissinfo.ch is a public service media company based in Bern Switzerland. It publishes independent news and information in 10 languages about Switzerland for a global audience.

  continue reading

88 episodes

Artwork
iconShare
 
Manage episode 414103800 series 32428
Content provided by SWI swissinfo.ch. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SWI swissinfo.ch or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Send us a Text Message.

Pharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production. Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines.
Articles and videos on Switzerland's investment in Slovenia are available on swissinfo.ch. For other science stories from Switzerland please go to www.swissinfo.ch/science.
Journalist: Jessica Davis Plüss
Host: Jo Fahy
Audio editor/video journalist: Céline Stegmüller & Michele Andina
Distribution and Marketing: Xin Zhang

SWI swissinfo.ch is a public service media company based in Bern Switzerland. It publishes independent news and information in 10 languages about Switzerland for a global audience.

  continue reading

88 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide